Bioceltix S.A. Logo

Bioceltix S.A.

BCX | WAR

Overview

Corporate Details

ISIN(s):
PLBCLTX00019 (+1 more)
LEI:
259400QZD5JYK8SLZU51
Country:
Poland
Address:
Wrocław Bierutowska 57-59/BUD.III, 51-317 Wrocław
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Bioceltix S.A. is a biotechnology company specializing in the development of innovative biological medicines for the veterinary sector. The company focuses on creating 'off-the-shelf' biopharmaceuticals derived from mesenchymal stem cells for the treatment of diseases in companion animals. Utilizing its proprietary, scalable ALLO-BCLX technology, Bioceltix develops allogeneic stem cell therapies targeting common conditions, including degenerative joint disease in dogs and cats. The company's operations span from research and development to establishing manufacturing capabilities for its advanced veterinary therapeutics.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Bioceltix S.A.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2024-05-07 18:29
Declaration of Voting Results & Voting Rights Announcements
Informacja o liczbie akcji i głosów
Polish 74.3 KB
2024-05-07 18:29
Governance Information
Klauzula informacyjna o przetwarzaniu danych osobowych
Polish 174.2 KB
2024-05-07 18:29
Proxy Solicitation & Information Statement
Formularz głosowania przez pełnomocnika
Polish 160.9 KB
2024-05-07 18:29
Proxy Solicitation & Information Statement
Formularze pełnomocnictwa
Polish 115.1 KB
2024-05-07 18:29
Registration Form
Zestawienie zmian statutu
Polish 86.8 KB
2024-05-07 18:29
Share Issue/Capital Change
Opinia Zarządu
Polish 73.1 KB
2024-05-07 18:29
Post-Annual General Meeting Information
Projekty uchwał wraz z uzasadnieniem
Polish 148.9 KB
2024-05-07 18:29
Pre-Annual General Meeting Information
Ogłoszenie o zwołaniu NWZ
Polish 145.2 KB
2024-05-07 18:29
Pre-Annual General Meeting Information
Zwołanie NWZ na dzień 3 czerwca 2024 roku - Content (PL)
Polish 2.1 KB
2024-05-07 17:38
Share Issue/Capital Change
Przyjęcie planu budowy wielkoskalowej wytwórni komórek macierzystych i sposobu …
Polish 5.4 KB
2024-04-26 17:12
Annual / Quarterly Financial Statement
Podpisy do opinii biegłego rewidenta z badania Sprawozdania Finansowego Biocelt…
Polish 10.3 KB
2024-04-26 17:12
Annual / Quarterly Financial Statement
Opinia biegłego rewidenta z badania Sprawozdania Finansowego Bioceltix S.A. za …
Polish 2.9 MB
2024-04-26 17:12
Annual / Quarterly Financial Statement
Podpisy do Raportu okresowego rocznego Bioceltix S.A. za rok 2023
Polish 20.9 KB
2024-04-26 17:12
Annual Report
Raport okresowy roczny Bioceltix S.A. za rok 2023
Polish 17.3 MB
2024-04-26 17:12
Annual Report
Podpisy do Sprawozdania z Działalności Bioceltix S.A. za okres sprawozdawczy za…
Polish 20.9 KB

Automate Your Workflow. Get a real-time feed of all Bioceltix S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Bioceltix S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK